IRADIMED CORPORATION (IRMD) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in CapitalUSD $31.59M; Retained Earnings (Accumulated Deficit)USD $70.15M; Stockholders' Equity Attributable to ParentUSD $101.75M.
- 2026-03-31: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in CapitalUSD $31.02M; Retained Earnings (Accumulated Deficit)USD $67.49M; Stockholders' Equity Attributable to ParentUSD $98.51M.
- 2025-12-31: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in CapitalUSD $30.39M; Retained Earnings (Accumulated Deficit)USD $64.23M; Stockholders' Equity Attributable to ParentUSD $94.62M.
- 2025-09-30: Common Stock, Value, IssuedUSD $1.27K; Additional Paid in CapitalUSD $32.01M; Retained Earnings (Accumulated Deficit)USD $66.34M; Stockholders' Equity Attributable to ParentUSD $98.35M.
IRADIMED CORPORATION Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Preferred Stock, Value, Issued USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Treasury Stock, Shares, Acquired shares | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00K | $31.59M | $70.15M | $101.75M | 3 month · $807.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $1.00K | $31.02M | $67.49M | $98.51M | 3 month · $684.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $1.00K | $30.39M | $64.23M | $94.62M | 12 month · $2.92M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $1.27K | $32.01M | $66.34M | $98.35M | 3 month · $666.08K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $1.27K | $31.37M | $62.93M | $94.30M | 3 month · $730.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $1.27K | $30.74M | $59.32M | $90.06M | 3 month · $826.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $1.00K | $30.03M | $56.79M | $86.82M | 12 month · $2.52M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $1.27K | $29.89M | $53.55M | $83.43M | 3 month · $629.97K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $1.27K | $29.27M | $50.40M | $79.67M | 3 month · $609.10K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $1.27K | $28.73M | $47.39M | $76.12M | 3 month · $628.64K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $1.26K | $28.16M | $43.26M | $71.42M | 12 month · $2.19M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $1.26K | $27.87M | $46.69M | $74.57M | 3 month · $533.75K | (m) | (m) | $0.00 | (m) | (m) | (m) |
| 2023-06-30 | $1.26K | $27.37M | $41.63M | $69.00M | 3 month · $568.45K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $1.26K | $26.89M | $37.45M | $64.34M | 3 month · $533.64K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $1.26K | $26.41M | $47.26M | $73.67M | 12 month · $1.39M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $1.26K | $26.18M | $43.59M | $69.77M | 3 month · $393.19K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $1.26K | $25.73M | $40.16M | $65.90M | 3 month · $121.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $1.26K | $25.62M | $36.92M | $62.55M | 3 month · $453.36K | (m) | (m) | $6.13K | (m) | (m) | (m) |
| 2021-12-31 | $1.25K | $25.16M | $46.99M | $72.17M | 12 month · $1.46M | (m) | (m) | $17.01K | (m) | (m) | (m) |
| 2021-09-30 | $1.23K | $24.77M | $43.10M | $67.89M | 3 month · $361.84K | (m) | (m) | $21.23K | (m) | (m) | (m) |
| 2021-06-30 | $1.23K | $24.35M | $40.53M | $64.90M | 3 month · $358.01K | (m) | (m) | $24.18K | (m) | (m) | (m) |
| 2021-03-31 | $1.23K | $23.99M | $39.06M | $63.08M | 3 month · $347.74K | (m) | (m) | $32.22K | (m) | (m) | (m) |
| 2020-12-31 | $1.23K | $23.68M | $37.67M | $61.38M | 12 month · $3.96M | (m) | (m) | $37.09K | (m) | (m) | (m) |
| 2020-09-30 | $1.23K | $23.64M | $37.03M | $60.72M | 3 month · $416.52K | (m) | (m) | $46.76K | (m) | (m) | (m) |
| 2020-06-30 | $1.22K | $22.35M | $35.96M | $58.36M | 3 month · $2.66M | (m) | (m) | $53.94K | (m) | (m) | (m) |
| 2020-03-31 | $1.20K | $19.95M | $38.07M | $58.06M | 3 month · $568.96K | (m) | (m) | $40.81K | (m) | (m) | (m) |
| 2019-12-31 | $1.18K | $19.19M | $36.30M | $55.52M | 12 month · $1.85M | (m) | (m) | $30.37K | (m) | (m) | (m) |
| 2019-09-30 | $1.14K | $18.68M | $33.06M | $51.77M | 3 month · $455.64K | (m) | (m) | $29.14K | (m) | (m) | (m) |
| 2019-06-30 | $1.12K | $16.52M | $30.60M | $47.15M | 3 month · $468.44K | (m) | (m) | $23.27K | (m) | (m) | (m) |
| 2019-03-31 | $1.11K | $16.13M | $28.52M | $44.65M | 3 month · $382.35K | (m) | (m) | $-4.00K | (m) | (m) | (m) |
| 2018-12-31 | $1.10K | $15.32M | $26.67M | $41.95M | 12 month · $1.76M | (m) | (m) | $-42.19K | (m) | (m) | (m) |
| 2018-09-30 | $1.09K | $15.20M | $24.96M | $40.09M | (m) | (m) | (m) | $-74.66K | (m) | (m) | (m) |
| 2018-06-30 | $1.07K | $13.70M | $22.56M | $36.17M | (m) | (m) | (m) | $-97.32K | (m) | (m) | (m) |
| 2018-03-31 | $1.06K | $13.13M | $21.21M | $34.24M | 3 month · $416.33K | (m) | (m) | $-102.48K | (m) | (m) | (m) |
| 2017-12-31 | $1.06K | $12.62M | $20.36M | $32.93M | 12 month · $2.45M | (m) | (m) | $-48.91K | (m) | (m) | (m) |
| 2017-09-30 | $1.08K | $13.81M | $20.17M | $32.14M | (m) | (m) | $1.82M | $-22.63K | (m) | (m) | (m) |
| 2017-06-30 | $1.08K | $12.90M | $19.98M | $31.30M | (m) | (m) | $1.55M | $-26.33K | (m) | (m) | (m) |
| 2017-03-31 | $1.07K | $12.43M | $19.62M | $32.03M | (m) | (m) | (m) | $-31.67K | (m) | (m) | (m) |
| 2016-12-31 | $1.07K | $12.06M | $19.87M | $31.89M | 12 month · $1.84M | (m) | (m) | $-36.85K | (m) | (m) | (m) |
| 2016-09-30 | $1.13K | $21.89M | $18.73M | $30.64M | (m) | (m) | $9.97M | $-5.39K | (m) | 8 month · 569.21K | (m) |
| 2016-06-30 | $1.12K | $21.28M | $17.17M | $28.47M | (m) | (m) | $9.97M | $-14.44K | (m) | 5 month · 569.21K | (m) |
| 2016-03-31 | $1.12K | $19.85M | $14.94M | $29.25M | (m) | (m) | $5.51M | $-41.19K | (m) | 2 month · 314.95K | 3 month · $-4.26K |
| 2015-12-31 | $1.12K | $19.33M | $12.66M | $31.93M | 12 month · $1.22M | (m) | (m) | $-55.28K | (m) | (m) | 12 month · $-2.24K |
| 2015-09-30 | $1.11K | $17.90M | $10.25M | $28.11M | (m) | (m) | (m) | $-35.82K | (m) | (m) | (m) |
| 2015-06-30 | $1.10K | $16.73M | $8.38M | $25.09M | (m) | (m) | (m) | $-25.48K | (m) | (m) | (m) |
| 2015-03-31 | $1.10K | $16.37M | $6.61M | $22.97M | (m) | (m) | (m) | $-12.08K | (m) | (m) | (m) |
| 2014-12-31 | $1.08K | $15.79M | $5.13M | $20.89M | 12 month · $724.06K | (m) | (m) | $-21.47K | 12 month · $2.04M | (m) | 12 month · $4.76K |
| 2014-09-30 | $1.07K | $15.30M | $4.85M | $20.15M | 9 month · $503.88K | (m) | (m) | (m) | 9 month · $2.04M | (m) | 3 month · $4.75K 9 month · $4.76K |
| 2014-06-30 | $700.00 | $2.68M | $4.62M | $7.30M | (m) | $140.00 | (m) | $4.62K | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.10K | (m) | (m) | (m) |
| 2013-12-31 | $700.00 | $2.35M | $3.07M | $5.42M | 12 month · $271.92K | $140.00 | (m) | $924.00 | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | $3.22M | (m) | (m) | (m) | $7.15K | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |